The conflict in Iran that is limiting fertilizer shipments through the Strait of Hormuz has pushed nitrogen producers into focus, with CVR Partners (UAN) drawing attention as supply tightens and ammonia prices respond.
See our latest analysis for CVR Partners.
At a share price of $131.26, CVR Partners has seen a 30 day share price return of 22.67% and a 90 day share price return of 37.47%, while the 1 year total shareholder return of 93.50% reflects strong long term gains. This suggests that recent conflict driven supply constraints and the early ammonia order book have sharpened investor focus rather than cooling it.
If you are looking beyond fertilizers and want to see what else is catching attention in infrastructure tied to big structural themes, it could be worth scanning 26 power grid technology and infrastructure stocks
With CVR Partners trading at an implied intrinsic discount of about 34% and posting a 1-year total return of 93.50%, the key question now is whether there is still a buying opportunity here or if the market is already pricing in future growth.
Preferred P/E of 14.1x: Is it justified?
CVR Partners is trading on a P/E of 14.1x at a last close of $131.26, which screens as inexpensive compared with both the US Chemicals industry average and its closest peers.
The P/E ratio compares the company’s share price to its earnings per unit, so a lower figure often indicates the market is paying less for each dollar of current earnings.
Here, the 14.1x P/E sits well below the US Chemicals industry average of 27.1x and the peer average of 28.2x. The company has high quality earnings and has moved into profitability over the past five years, with earnings growth of 11.2% per year over that period and 62% earnings growth in the last year, alongside a net profit margin of 16.3% compared with 11.6% a year earlier.
That gap suggests the market is currently valuing CVR Partners’ earnings at a clear discount to sector and peer pricing, even though recent earnings growth exceeds the Chemicals industry result of a 2.5% decline over the same period.
See what the numbers say about this price — find out in our valuation breakdown.
Result: Price-to-earnings of 14.1x (UNDERVALUED)
However, you still need to weigh risks such as any easing of Strait of Hormuz disruptions or a pullback in ammonia pricing that cools current enthusiasm.
Find out about the key risks to this CVR Partners narrative.
Another view: DCF paints a fuller picture
While the 14.1x P/E points to a discount against US Chemicals peers, the SWS DCF model adds another layer. On this view, CVR Partners at $131.26 trades below an estimated future cash flow value of $200.22, which also flags the units as undervalued.
The two approaches are pointing in the same direction, but each leans on different assumptions about future cash flows, fertilizer pricing and capital intensity. The key question is which set of assumptions feels more realistic over your holding period, and how much margin of safety that really offers.
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out CVR Partners for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 49 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
With sentiment clearly mixed, and both risks and rewards on the table, it helps to check the numbers yourself and decide quickly where you stand. To weigh both sides in one place, start with the 2 key rewards and 2 important warning signs
Looking for more investment ideas?
Do not stop your research with a single stock, broaden your watchlist now so you are not chasing opportunities after everyone else has moved.
- Spot potential bargains early by scanning 49 high quality undervalued stocks that combine appealing pricing with underlying business strength.
- Prioritise resilience first and see which companies show up in the 72 resilient stocks with low risk scores designed to highlight steadier profiles.
- Get ahead of the crowd by checking the screener containing 25 high quality undiscovered gems before these names attract wider attention.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com